Form 4: Winmark Director Exercises Options, Sells 2,400 Shares
Insider Transaction Report
A Winmark Corp. director exercised stock options and subsequently sold 2,400 shares of common stock for $420.87 per share.
Summary
- Jenele C. Grassle, a Director of Winmark Corp. (WINA), engaged in a series of transactions involving the company's common stock.
- On November 19, 2025, Grassle exercised stock options to acquire a total of 2,400 shares of common stock.
- These options were exercised at prices of $98.25, $125.50, and $122.50 per share.
- Following the option exercises, on November 21, 2025, Grassle sold all 2,400 newly acquired shares at a price of $420.87 per share.
- The transactions were conducted pursuant to a Rule 10b5-1 trading plan.
- After these transactions, Grassle directly owns 2,500 shares of Winmark Corp. common stock and holds options for an additional 10,100 shares.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions (exercise and sell) executed under a Rule 10b5-1 plan, which is generally considered neutral as it's pre-scheduled and not indicative of new sentiment.
Positives
- The sale price of $420.87 per share represents a significant gain over the exercise prices, indicating profitable option exercises.
- The transactions were executed under a Rule 10b5-1 plan, suggesting a pre-planned and routine diversification or liquidity event rather than a reaction to new, non-public information.
Negatives
- The sale of 2,400 shares by a director could be perceived as a reduction in direct equity exposure, although it is offset by remaining option holdings.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The sale of shares by a director could be viewed as a slight reduction in direct insider ownership, but the pre-planned nature mitigates negative interpretations.
- Employees: No direct impact.
- Customers: No direct impact.
- Suppliers: No direct impact.
- Creditors: No direct impact.
Key Dates
| Date | Description |
|---|---|
| 06/01/2017 | Date exercisable for 800 stock options with an exercise price of $98.25, expiring 06/01/2026. |
| 12/12/2017 | Date exercisable for 800 stock options with an exercise price of $125.50, expiring 12/12/2026. |
| 06/01/2018 | Date exercisable for 800 stock options with an exercise price of $122.50, expiring 06/01/2027. |
| 12/11/2018 | Date exercisable for 800 stock options with an exercise price of $134.25, expiring 12/11/2027. |
| 06/01/2019 | Date exercisable for 800 stock options with an exercise price of $143.20, expiring 06/01/2028. |
| 12/11/2019 | Date exercisable for 800 stock options with an exercise price of $156.00, expiring 12/11/2028. |
| 06/01/2020 | Date exercisable for 750 stock options with an exercise price of $164.84, expiring 06/01/2029. |
| 12/16/2020 | Date exercisable for 750 stock options with an exercise price of $176.20, expiring 12/16/2029. |
| 06/01/2021 | Date exercisable for 750 stock options with an exercise price of $143.87, expiring 06/01/2030. |
| 12/14/2021 | Date exercisable for 750 stock options with an exercise price of $183.87, expiring 12/14/2030. |
| 06/01/2022 | Date exercisable for 750 stock options with an exercise price of $195.82, expiring 06/01/2031. |
| 12/13/2022 | Date exercisable for 750 stock options with an exercise price of $261.32, expiring 12/13/2031. |
| 06/01/2023 | Date exercisable for 880 stock options with an exercise price of $197.80, expiring 06/01/2032. |
| 12/12/2023 | Date exercisable for 620 stock options with an exercise price of $238.60, expiring 12/12/2032. |
| 06/01/2024 | Date exercisable for 380 stock options with an exercise price of $325.99, expiring 06/01/2033. |
| 12/01/2024 | Date exercisable for 240 stock options with an exercise price of $446.68, expiring 12/01/2033. |
| 06/01/2025 | Date exercisable for 300 stock options with an exercise price of $355.90, expiring 06/01/2034. |
| 11/19/2025 | Date of option exercises for 2,400 shares of common stock. |
| 11/21/2025 | Date of sale of 2,400 shares of common stock. |
| 12/09/2025 | Date exercisable for 300 stock options with an exercise price of $400.97, expiring 12/09/2034. |
| 06/01/2026 | Date exercisable for 280 stock options with an exercise price of $424.82, expiring 06/01/2035. |
Recommendation
holdThis Form 4 filing details a routine exercise of stock options and subsequent sale of shares by a director under a Rule 10b5-1 plan. Such pre-planned transactions are common for diversification and liquidity and typically do not reflect a change in the insider's view of the company's fundamental prospects. Therefore, this filing alone does not warrant a change in investment recommendation; a 'hold' stance remains appropriate, pending further fundamental analysis of Winmark Corp.
Keywords
Winmark Corp, WINA, Insider Trading, Form 4, Stock Options, Director Transactions, Equity Sales, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.